<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Libyan J Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Libyan J Med</journal-id>
      <journal-id journal-id-type="publisher-id">LJM</journal-id>
      <journal-title-group>
        <journal-title>The Libyan Journal of Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1993-2820</issn>
      <issn pub-type="epub">1819-6357</issn>
      <publisher>
        <publisher-name>Co-Action Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23958458</article-id>
      <article-id pub-id-type="pmc">3746081</article-id>
      <article-id pub-id-type="publisher-id">22391</article-id>
      <article-id pub-id-type="doi">10.3402/ljm.v8i0.22391</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Iloprost in pulmonary hypertension due to sub-massive pulmonary embolism: report of two cases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Alsaghir</surname>
            <given-names>Abdullah Hassan</given-names>
          </name>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alaithan</surname>
            <given-names>Soror Abdullah</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alsihati</surname>
            <given-names>Basima</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alhajjaj</surname>
            <given-names>Dhia Naji</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>Department of Medicine, Dammam Medical Complex, Dammam, Saudi Arabia</aff>
      <author-notes>
        <corresp id="cor1"><label>*</label>Email: <email xlink:href="asaghir4000@yahoo.com">asaghir4000@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>8</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id content-type="doi">10.3402/ljm.v8i0.22391</elocation-id>
      <permissions>
        <copyright-statement>&#xA9; 2013 Abdullah Hassan Alsaghir et al.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Patients with acute pulmonary embolism (PE) who has normal systemic arterial pressure and right ventricular (RV) dysfunction are considered to have sub-massive pulmonary embolism (SPE), with 3-month mortality risk of 21% (<xref ref-type="bibr" rid="CIT0001">1</xref>). The benefit of the current therapy other than anticoagulation including thrombolytic therapy (TT), embolectomy, and IVC filter insertion, in the absence of cardiogenic shock, is still debated (<xref ref-type="bibr" rid="CIT0002">2</xref>). Vasoconstrictive mediators (including thromboxane-A and serotonin) have an important role to play in the increase of peripheral vascular resistance (PVR) and ultimately in developing pulmonary hypertension (PH) in acute phase (<xref ref-type="bibr" rid="CIT0003">3</xref>, <xref ref-type="bibr" rid="CIT0004">4</xref>). A study by Idrees et al. described a beneficial effect of inhaled iloprost in five patients with SPE, in whom there is an improvement in WHO-functional class (WHO-FC), 6-min walk distance (6MWD) test, and echocardiographic parameters (<xref ref-type="bibr" rid="CIT0005">5</xref>). Iloprost, an inhaled prostacyclin approved for the treatment of patients with pulmonary arterial hypertension, exerts long-term benefits through antiproliferative and antithrombotic effects, but is also a potent acute pulmonary vasodilator with the duration of action of approximately 60 min (<xref ref-type="bibr" rid="CIT0006">6</xref>).</p>
    <p>Two patients were evaluated at the Dammam Medical Complex, Dammam, Saudi Arabia between June and December 2012. The diagnosis of PE was established by helical computed tomography (CT) angiogram that showed a thrombus at both pulmonary arteries at presentation. They had normal systemic blood pressure, PH documented by echocardiography demonstrated an estimated systolic pulmonary artery pressure &gt;45 mm Hg and findings of RV dysfunction suggestive of acute changes. Both patients received therapeutic anticoagulation with low-molecular-weight heparin and targeted warfarin dose to international normalized ratio of 2&#x2013;3. They were still symptomatic and required more oxygen, for which they were offered TT. They declined TT, but agreed to receive inhaled iloprost through a nebulized device of 2.5&#x2013;5.0 &#xB5;g per inhalation for 15 min, 8&#xD7; daily for 3 months.</p>
    <p>The main efficacy index was defined as the changes in WHO-FC, 6MWD, oxygen saturation, and echocardiography parameters during 3-month inhalation therapy. These parameters were assessed at baseline, 3-month post-inhalation, and 3-month post-cessation of iloprost. Both patients tolerated the treatment well. They showed significant improvement in their clinical symptoms and echocardiographic parameters (<xref ref-type="table" rid="T0001">Table 1</xref>, <xref ref-type="fig" rid="F0001">Figure 1</xref>).
</p>
    <fig id="F0001" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>The mean of WHO functional class, 6MWD, and sPAP (by echo) pre- and 3 months post and 3 months post-cessation of iloprost.</p>
      </caption>
      <graphic xlink:href="LJM-8-22391-g001"/>
    </fig>
    <table-wrap id="T0001" position="float">
      <label>Table 1</label>
      <caption>
        <p>Clinical and physiological parameters of both patients before and after iloprost (3 months before and 3 months post-cessation of iloprost)</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" rowspan="1" colspan="1">Measurement</th>
            <th align="center" rowspan="1" colspan="1">Pre-iloprost</th>
            <th align="center" rowspan="1" colspan="1">3 months post-iloprost</th>
            <th align="center" rowspan="1" colspan="1">3 months post-cessation of iloprost</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td colspan="4" align="left" rowspan="1">
<bold>Case 1</bold>
</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">WHO functional class</td>
            <td align="center" rowspan="1" colspan="1">III</td>
            <td align="center" rowspan="1" colspan="1">I</td>
            <td align="center" rowspan="1" colspan="1">I</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">6MWD</td>
            <td align="center" rowspan="1" colspan="1">176 m</td>
            <td align="center" rowspan="1" colspan="1">408 m</td>
            <td align="center" rowspan="1" colspan="1">422 m</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Oxygen saturation</td>
            <td align="center" rowspan="1" colspan="1">90% on RA</td>
            <td align="center" rowspan="1" colspan="1">97% on RA</td>
            <td align="center" rowspan="1" colspan="1">97% on RA</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1">98% on 2 L/min</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">sPAP (by echo)</td>
            <td align="center" rowspan="1" colspan="1">&gt;70 mm Hg</td>
            <td align="center" rowspan="1" colspan="1">30 mm Hg</td>
            <td align="center" rowspan="1" colspan="1">25 mm Hg</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">RV dysfunction</td>
            <td align="center" rowspan="1" colspan="1">Severe</td>
            <td align="center" rowspan="1" colspan="1">Normal</td>
            <td align="center" rowspan="1" colspan="1">Normal</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Qualitative score</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td colspan="4" align="left" rowspan="1">
<bold>Case 2</bold>
</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">WHO functional class</td>
            <td align="center" rowspan="1" colspan="1">IV</td>
            <td align="center" rowspan="1" colspan="1">I</td>
            <td align="center" rowspan="1" colspan="1">I</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">6MWD</td>
            <td align="center" rowspan="1" colspan="1">138 m</td>
            <td align="center" rowspan="1" colspan="1">418 m</td>
            <td align="center" rowspan="1" colspan="1">434 m</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Oxygen saturation</td>
            <td align="center" rowspan="1" colspan="1">89% on RA</td>
            <td align="center" rowspan="1" colspan="1">98% on RA</td>
            <td align="center" rowspan="1" colspan="1">98% on RA</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1">97% on 2 L/min</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">sPAP (by echo)</td>
            <td align="center" rowspan="1" colspan="1">80 mm Hg</td>
            <td align="center" rowspan="1" colspan="1">25 mm Hg</td>
            <td align="center" rowspan="1" colspan="1">25 mm Hg</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">RV dysfunction</td>
            <td align="center" rowspan="1" colspan="1">Moderate</td>
            <td align="center" rowspan="1" colspan="1">Normal</td>
            <td align="center" rowspan="1" colspan="1">Normal</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Qualitative score</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <p>In conclusion, iloprost might have favorable acute effects on symptoms, exercise tolerance, and pulmonary hypertension in sub-massive pulmonary embolism.</p>
    <sig-block>
      <sig><italic>Abdullah Hassan Alsaghir</italic><break/> Department of Medicine<break/> Dammam Medical Complex<break/> Dammam, Saudi Arabia<break/>Email: asaghir4000@yahoo.com</sig>
      <break/>
      <break/>
      <sig><italic>Soror Abdullah Alaithan</italic><break/> Department of Medicine<break/> Dammam Medical Complex<break/> Dammam, Saudi Arabia</sig>
      <break/>
      <break/>
      <sig><italic>Basima Alsihati</italic><break/> Department of Medicine<break/> Dammam Medical Complex<break/> Dammam, Saudi Arabia</sig>
      <break/>
      <break/>
      <sig><italic>Dhia Naji Alhajjaj</italic><break/> Department of Medicine<break/> Dammam Medical Complex<break/> Dammam, Saudi Arabia</sig>
    </sig-block>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lindmarker</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Juhlin-Dannfelt</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jonhsson</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jorfeldt</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Echocardiography Doppler in pulmonary embolism: RV dysfunction as a predictor of mortality rate</article-title>
          <source>Am Heart J</source>
          <year>1997</year>
          <volume>134</volume>
          <fpage>479</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="pmid">9327706</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0002">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Konstantinides</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Geibel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Heusel</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Heinrich</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kasper</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism</article-title>
          <source>N Engl J Med</source>
          <year>2002</year>
          <volume>347</volume>
          <fpage>1143</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">12374874</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0003">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reeves</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Demers</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>The release of thromboxane A and prostacyclin following experimental acute pulmonary embolism</article-title>
          <source>Prostagl Leukotr Med</source>
          <year>1983</year>
          <volume>11</volume>
          <fpage>1</fpage>
          <lpage>10</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0004">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egermayer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Peacock</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension</article-title>
          <source>Thorax</source>
          <year>1999</year>
          <volume>54</volume>
          <fpage>161</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">10325923</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0005">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Idrees</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Batubara</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kashour</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Novel approach for the management of sub-massive pulmonary embolism</article-title>
          <source>Ann Thoracic Med</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>157</fpage>
          <lpage>61</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0006">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olschewski</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Simonneau</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Aerosolized Iloprost Randomized Study Group. Inhaled iloprost for severe pulmonary hypertension</article-title>
          <source>N Engl J Med</source>
          <year>2002</year>
          <volume>347</volume>
          <fpage>322</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">12151469</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
